Global Allergy Immunotherapy Market by Type (SCIT, SLIT), Allergy Type (Allergic Rhinitis, Asthma, Food Allergy), Distribution Channel - Forecast 2024-2030- Product Image

Sale

Global Allergy Immunotherapy Market by Type (SCIT, SLIT), Allergy Type (Allergic Rhinitis, Asthma, Food Allergy), Distribution Channel - Forecast 2024-2030

Report
184 Pages
March 2024
Region: Global
360iResearch™
ID: 4905050

UP TO €846EUR$875USD£725GBP OFF until Dec 31^st 2024

The Allergy Immunotherapy Market size was estimated at USD 4.48 billion in 2023, USD 4.86 billion in 2024, and is expected to grow at a CAGR of 8.60% to reach USD 7.98 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Allergy Immunotherapy Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Allergy Immunotherapy Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Allergy Immunotherapy Market, highlighting leading vendors and their innovative profiles. These include Adamis Pharmaceuticals Corporation, ALK-Abelló, Inc., Allergy Therapeutics PLC, ASIT Biotech by DMS Imaging, BioSpace, Inc., Circassia Group PLC, DBV Technologies SA, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., HAL Allergy B.V., HollisterStier Allergy by Jubilant Pharma Company, LETI Pharma, S.L.U., Merck KGaA, Mylan N.V. by Viatris Inc., and Stallergenes Greer International AG.

Market Segmentation & Coverage

This research report categorizes the Allergy Immunotherapy Market to forecast the revenues and analyze trends in each of the following sub-markets:

Type
- SCIT
- SLIT
Allergy Type
- Allergic Rhinitis
- Asthma
- Food Allergy
- Venom Allergy
Distribution Channel
- Hospital Pharmacy
- Online Pharmacy
- Retail Pharmacy and Drug Stores

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report offers valuable insights on the following aspects

Market Penetration: It presents comprehensive information on the market provided by key players.
Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as

What is the market size and forecast of the Allergy Immunotherapy Market?
Which products, segments, applications, and areas should one consider investing in over the forecast period in the Allergy Immunotherapy Market?
What are the technology trends and regulatory frameworks in the Allergy Immunotherapy Market?
What is the market share of the leading vendors in the Allergy Immunotherapy Market?
Which modes and strategic moves are suitable for entering the Allergy Immunotherapy Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Allergy Immunotherapy Market, by Region

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rise in demand due to increasing prevalence of allergies
5.1.1.2. Surge in demand due to shift in lifestyle and environmental factors
5.1.1.3. Rising awareness among people about advanced immunotherapies
5.1.2. Restraints
5.1.2.1. Higher upfront cost of treatment
5.1.2.2. Risk of side effects such redness, swelling, and tenderness
5.1.3. Opportunities
5.1.3.1. Increasing healthcare expenditure in the developing economies
5.1.3.2. Increase in regulatory approvals
5.1.4. Challenges
5.1.4.1. Lack of skilled professionals
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. Allergy Immunotherapy Market, by Type

6.1. Introduction
6.2. SCIT
6.3. SLIT

7. Allergy Immunotherapy Market, by Allergy Type

7.1. Introduction
7.2. Allergic Rhinitis
7.3. Asthma
7.4. Food Allergy
7.5. Venom Allergy

8. Allergy Immunotherapy Market, by Distribution Channel

8.1. Introduction
8.2. Hospital Pharmacy
8.3. Online Pharmacy
8.4. Retail Pharmacy and Drug Stores

9. Americas Allergy Immunotherapy Market

9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Allergy Immunotherapy Market

10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa Allergy Immunotherapy Market

11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape

12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player

13. Competitive Portfolio

13.1. Key Company Profiles
13.1.1. Adamis Pharmaceuticals Corporation
13.1.2. ALK-Abelló, Inc.
13.1.3. Allergy Therapeutics PLC
13.1.4. ASIT Biotech by DMS Imaging
13.1.5. BioSpace, Inc.
13.1.6. Circassia Group PLC
13.1.7. DBV Technologies SA
13.1.8. Eli Lilly and Company
13.1.9. F. Hoffmann-La Roche Ltd.
13.1.10. HAL Allergy B.V.
13.1.11. HollisterStier Allergy by Jubilant Pharma Company
13.1.12. LETI Pharma, S.L.U.
13.1.13. Merck KGaA
13.1.14. Mylan N.V. by Viatris Inc.
13.1.15. Stallergenes Greer International AG
13.2. Key Product Portfolio

14. Appendix

14.1. Discussion Guide
14.2. License & Pricing

List of Figures

FIGURE 1. ALLERGY IMMUNOTHERAPY MARKET RESEARCH PROCESS
FIGURE 2. ALLERGY IMMUNOTHERAPY MARKET SIZE, 2023 VS 2030
FIGURE 3. ALLERGY IMMUNOTHERAPY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. ALLERGY IMMUNOTHERAPY MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. ALLERGY IMMUNOTHERAPY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. ALLERGY IMMUNOTHERAPY MARKET DYNAMICS
FIGURE 7. ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 8. ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2023 VS 2030 (%)
FIGURE 10. ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
FIGURE 12. ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS ALLERGY IMMUNOTHERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS ALLERGY IMMUNOTHERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC ALLERGY IMMUNOTHERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC ALLERGY IMMUNOTHERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. ALLERGY IMMUNOTHERAPY MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 22. ALLERGY IMMUNOTHERAPY MARKET SHARE, BY KEY PLAYER, 2023

List of Tables

TABLE 1. ALLERGY IMMUNOTHERAPY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. ALLERGY IMMUNOTHERAPY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 6. ALLERGY IMMUNOTHERAPY MARKET SIZE, BY SCIT, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. ALLERGY IMMUNOTHERAPY MARKET SIZE, BY SLIT, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
TABLE 9. ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGIC RHINITIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ASTHMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. ALLERGY IMMUNOTHERAPY MARKET SIZE, BY FOOD ALLERGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. ALLERGY IMMUNOTHERAPY MARKET SIZE, BY VENOM ALLERGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 14. ALLERGY IMMUNOTHERAPY MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. ALLERGY IMMUNOTHERAPY MARKET SIZE, BY RETAIL PHARMACY AND DRUG STORES, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. AMERICAS ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 18. AMERICAS ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
TABLE 19. AMERICAS ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 20. AMERICAS ALLERGY IMMUNOTHERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 21. ARGENTINA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 22. ARGENTINA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
TABLE 23. ARGENTINA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 24. BRAZIL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 25. BRAZIL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
TABLE 26. BRAZIL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 27. CANADA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 28. CANADA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
TABLE 29. CANADA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 30. MEXICO ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 31. MEXICO ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
TABLE 32. MEXICO ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 33. UNITED STATES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 34. UNITED STATES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
TABLE 35. UNITED STATES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 36. UNITED STATES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 37. ASIA-PACIFIC ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 38. ASIA-PACIFIC ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
TABLE 39. ASIA-PACIFIC ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 40. ASIA-PACIFIC ALLERGY IMMUNOTHERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 41. AUSTRALIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 42. AUSTRALIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
TABLE 43. AUSTRALIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 44. CHINA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 45. CHINA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
TABLE 46. CHINA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 47. INDIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 48. INDIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
TABLE 49. INDIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 50. INDONESIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 51. INDONESIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
TABLE 52. INDONESIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 53. JAPAN ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 54. JAPAN ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
TABLE 55. JAPAN ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 56. MALAYSIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 57. MALAYSIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
TABLE 58. MALAYSIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 59. PHILIPPINES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 60. PHILIPPINES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
TABLE 61. PHILIPPINES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 62. SINGAPORE ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 63. SINGAPORE ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
TABLE 64. SINGAPORE ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 65. SOUTH KOREA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 66. SOUTH KOREA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
TABLE 67. SOUTH KOREA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 68. TAIWAN ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 69. TAIWAN ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
TABLE 70. TAIWAN ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 71. THAILAND ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 72. THAILAND ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
TABLE 73. THAILAND ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 74. VIETNAM ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 75. VIETNAM ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
TABLE 76. VIETNAM ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 77. EUROPE, MIDDLE EAST & AFRICA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 78. EUROPE, MIDDLE EAST & AFRICA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
TABLE 79. EUROPE, MIDDLE EAST & AFRICA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 80. EUROPE, MIDDLE EAST & AFRICA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 81. DENMARK ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 82. DENMARK ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
TABLE 83. DENMARK ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 84. EGYPT ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 85. EGYPT ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
TABLE 86. EGYPT ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 87. FINLAND ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 88. FINLAND ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
TABLE 89. FINLAND ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 90. FRANCE ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 91. FRANCE ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
TABLE 92. FRANCE ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 93. GERMANY ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 94. GERMANY ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
TABLE 95. GERMANY ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 96. ISRAEL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 97. ISRAEL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
TABLE 98. ISRAEL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 99. ITALY ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 100. ITALY ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
TABLE 101. ITALY ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 102. NETHERLANDS ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 103. NETHERLANDS ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
TABLE 104. NETHERLANDS ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 105. NIGERIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 106. NIGERIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
TABLE 107. NIGERIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 108. NORWAY ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 109. NORWAY ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
TABLE 110. NORWAY ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 111. POLAND ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 112. POLAND ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
TABLE 113. POLAND ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 114. QATAR ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 115. QATAR ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
TABLE 116. QATAR ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 117. RUSSIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 118. RUSSIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
TABLE 119. RUSSIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 120. SAUDI ARABIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 121. SAUDI ARABIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
TABLE 122. SAUDI ARABIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 123. SOUTH AFRICA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 124. SOUTH AFRICA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
TABLE 125. SOUTH AFRICA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 126. SPAIN ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 127. SPAIN ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
TABLE 128. SPAIN ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 129. SWEDEN ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 130. SWEDEN ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
TABLE 131. SWEDEN ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 132. SWITZERLAND ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 133. SWITZERLAND ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
TABLE 134. SWITZERLAND ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 135. TURKEY ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 136. TURKEY ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
TABLE 137. TURKEY ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 138. UNITED ARAB EMIRATES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 139. UNITED ARAB EMIRATES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
TABLE 140. UNITED ARAB EMIRATES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 141. UNITED KINGDOM ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 142. UNITED KINGDOM ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
TABLE 143. UNITED KINGDOM ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 144. ALLERGY IMMUNOTHERAPY MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 145. ALLERGY IMMUNOTHERAPY MARKET SHARE, BY KEY PLAYER, 2023
TABLE 146. ALLERGY IMMUNOTHERAPY MARKET LICENSE & PRICING

Companies Mentioned

Adamis Pharmaceuticals Corporation
ALK-Abelló, Inc.
Allergy Therapeutics PLC
ASIT Biotech by DMS Imaging
BioSpace, Inc.
Circassia Group PLC
DBV Technologies SA
Eli Lilly and Company
F. Hoffmann-La Roche Ltd.
HAL Allergy B.V.
HollisterStier Allergy by Jubilant Pharma Company
LETI Pharma, S.L.U.
Merck KGaA
Mylan N.V. by Viatris Inc.
Stallergenes Greer International AG

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	184
Published	March 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 4.86 Billion
Forecasted Market Value ( USD ) by 2030	$ 7.98 Billion
Compound Annual Growth Rate	8.6%
Regions Covered	Global
No. of Companies Mentioned	15

PURCHASE OPTIONS

Single User License Online Access - 1 Year

Single User License PDF, Excel And Online Access - 1 Year

1 - 5 User License PDF, Excel And Online Access - 1 Year

Site License PDF, Excel And Online Access - 1 Year

Enterprise License PDF, Excel And Online Access - 1 Year

need a quote ?

License	Format	Properties	Price
SINGLE USER LICENSE Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€3263EUR$3,374USD£2,796GBP €3625EUR$3,749USD£3,107GBP
SINGLE USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€4133EUR$4,274USD£3,542GBP €4593EUR$4,749USD£3,936GBP
1 - 5 USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a 1-5 user license, allowing up to five users have access to the product.	€5004EUR$5,174USD£4,288GBP €5560EUR$5,749USD£4,765GBP
SITE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5874EUR$6,074USD£5,034GBP €6527EUR$6,749USD£5,594GBP
ENTERPRISE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is an enterprise license, allowing all employees within your organization access to the product.	€7615EUR$7,874USD£6,526GBP €8461EUR$8,749USD£7,251GBP

FPNV Positioning Matrix

Market Share Analysis

Key Company Profiles

Market Segmentation & Coverage

The report offers valuable insights on the following aspects

The report addresses key questions such as

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Global Allergy Drugs Market by Type (Drug Allergy, Food Allergy, Inhaled Allergy), Treatment (Anti-allergy Drugs, Immunotherapy), Distribution Channels - Forecast 2024-2030

Allergy Immunotherapies Market Report by Treatment Type, Allergy Type, Distribution Channel, and Region 2024-2032

Global Allergy Immunotherapy Market Analysis & Forecast to 2023-2033: Market By Type; By Application; By Distribution Channel; and By Region

Allergy Immunotherapy Market Report 2023-2033

Global Allergy Immunotherapy Market Size, Share & Industry Trends Analysis Report By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, and Online Pharmacy), By Treatment Type, By Allergy Type, By Regional Outlook and Forecast, 2023 - 2030

About the Market